OMER, Israel, Jan. 7, 2014 /PRNewswire/ -- Medigus Ltd. (TASE: MDGS) announced today that Mr. Chris Rowland, CEO, will present at the 16th Annual Needham Growth Conference taking place at The New York Palace Hotel in New York CityJanuary 14 - 16, 2014. Mr. Rowland’s presentation is scheduled for Wednesday, January 15, 2014 at 12:05 p.m. EST.
To access a live webcast of this presentation, visit http://wsw.com/webcast/needham64/mdgs.ta. An archived recording will also be available for 90 days at the above-referenced website. Mr. Rowland will be available for one on one meetings throughout the conference.
About Medigus
Through the development of minimally invasive endoscopic devices, Medigus (TASE: MDGS) is leading the transition from invasive gastric surgery procedures to less invasive, patient-friendly techniques. The company’s revolutionary SRS system enables Gastroenterologists and Surgeons alike to treat gastroesophageal reflux disease (GERD), a chronic disease with increasing global prevalence, by performing a trans-oral fundoplication procedure. Unlike current fundoplication procedures, the SRS system does not require abdominal incisions which may result in shorter post-procedure recovery. The SRS system has received FDA clearance for marketing and CE mark.
To learn more about the company’s minimally invasive technology platform, please visit http://www.medigus.com/.
SOURCE Medigus Ltd.
Help employers find you! Check out all the jobs and post your resume.
